H.I.G. HealthBridge Partners


H.I.G. HealthBridge Partners is a growth equity fund that collaborates with growth-stage healthcare companies to enhance patient outcomes while reducing healthcare costs. The firm focuses on sectors such as medical devices, biopharmaceuticals, digital health, tools and diagnostics, and product-related services. With a seasoned investment team, H.I.G. HealthBridge Partners provides strategic support to its portfolio companies in areas like market strategy, growth initiatives, and operational excellence.

H.I.G. HealthBridge Partners

H.I.G. HealthBridge Partners

1450 Brickell Avenue, 31st Floor, Miami, FL 33131


What We Do

Assisting portfolio companies in developing and executing effective market entry and expansion strategies.

Supporting portfolio companies in identifying and pursuing growth opportunities, both through internal development and external acquisitions.

Helping portfolio companies attract and retain top management talent to drive business success.

Working with portfolio companies to enhance operational efficiency and support business expansion efforts.

Assisting portfolio companies in identifying and pursuing new business opportunities and partnerships.

Providing additional financial support to portfolio companies through equity and debt financing options.

Guiding portfolio companies towards successful exits through mergers, acquisitions, or initial public offerings.


Investment Range


Portfolio

Awarded 'Most Innovative Product of the Year' by Best in Biz for CYTALUX® (pafolacianine) injection.

#Healthcare

H.I.G. Capital completed the sale of BIOVECTRA, a leading company in its sector.

#Healthcare

Acquired the Spine Business of ZimVie, rebranded as Highridge Medical.

#Healthcare

Received start-up financing of $207.8 million, one of the largest initial financing commitments for a European-focused biopharmaceutical company.

#Biopharmaceuticals

Developed the OverStitch™ Endoscopic Suturing System, a new class of flexible surgical instruments.

#Medical Devices

Pioneer in augmented reality surgical navigation, raised $82.5 million to accelerate adoption of augmented reality spine surgery.

#Medical Devices

Developed the HeartLight X3 Endoscopic Ablation System for atrial fibrillation treatment.

#Medical Devices

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.